deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT00532246

Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

A Study of Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene HCl or Placebo

Sponsor: Eli Lilly and Company

Conditions Osteoporosis, Post-Menopausal
Interventions Placebo raloxifene
Updated 4 times since 2017 Last updated: Sep 18, 2007 Started: Mar 31, 2003 Completion: Aug 31, 2003
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Osteoporosis, Post-Menopausal, this trial is completed. The trial is conducted by Eli Lilly and Company and has accumulated 4 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jan 2021 · 48 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE4

    First recorded

Mar 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eli Lilly and Company
Data source: Eli Lilly and Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations